Ackman Accused of Insider Trading in Allergan Shareholder Suit

Bill Ackman, who made about $2.5 billion from his investment in botox-maker Allergan Inc. ahead of a takeover attempt by Valeant Pharmaceuticals International Inc., was accused of insider trading by an Allergan shareholder.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.